Seminars in Liver Disease
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.0 | Q2 | 73.2% | 1.450 | Q1 | 91.5% |
| 2024 | 3.7 | Q2 | 70.7% | 1.457 | Q1 | 91.8% |
| 2023 | 4.3 | Q1 | 81.8% | 1.856 | Q1 | 95.0% |
| 2022 | 4.2 | Q2 | 77.6% | 1.736 | Q1 | 94.6% |
| 2021 | 6.5 | Q2 | 82.4% | 1.934 | Q1 | 95.7% |
| 2020 | — | — | 1.874 | Q1 | 94.9% | |
| 2019 | — | — | 1.548 | Q1 | 93.0% | |
| 2018 | — | — | 1.859 | Q1 | 94.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0272-8087
ISSN
1098-8971
country
UScoverage
1981-2026